Correlation study of tumor-infiltrating lymphocytes combined with residual cancer burden and prognosis in breast cancer patients receiving neoadjuvant chemotherapy
RCB-TILs (+) are correlated with extended DFS in BC patients who have undergone surgery post-NAC. In these individuals, RCB-TILs may provide a more sensitive predictor of DFS than RCB or TILs individually.
Authors
- Guojian Liao (ORCID: https://orcid.org/0000-0001-6133-7625)
- Zexin Hou (ORCID: https://orcid.org/0000-0001-6586-5994)
- Gloria Meng
- Xin An (ORCID: https://orcid.org/0000-0003-0683-5511)
- Feng Li (ORCID: https://orcid.org/0000-0002-8559-3831)
- Hongmei Zhao (ORCID: https://orcid.org/0000-0003-2997-8945)
- Xiaomin Long
- S. Liao (ORCID: https://orcid.org/0000-0003-4564-1445)
- Lingjun Zou
- Wen Wu
Institutions
- Guiyang Medical University (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
- Shengli Oilfield Central Hospital (CN)
- Hua Medicine (China) (CN)
- Second People’s Hospital of Yibin (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-09-09
- DOI
- https://doi.org/10.3389/fonc.2025.1538326
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Health Commission of Guizhou Province